Picture of Lysogene SA logo

LYS Lysogene SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-55.11%
3m-50.52%
6m-59.55%
1yr-86.68%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-78.62%
Return on Equityn/a
Operating Margin-77.72%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Lysogene SA EPS forecast chart

Profile Summary

Lysogene SA is a France-based company principally engaged in the bio diagnostics and testing. The Company is focused on the gene therapy biotechnology. The Company develops treatments targeting severe genetic pathologies with central nervous system involvement and high unmet medical needs. It is specialized in the development of intracerebral gene therapy aimed at treating pathologies affecting the central nervous system, which is the main cause of neuro-degenerative disease mortality in children.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
April 15th, 2009
Public Since
February 8th, 2017
No. of Employees
23
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
17,797,984

LYS Share Price Performance

Upcoming Events for LYS

Lysogene SA Annual Shareholders Meeting

Similar to LYS

Picture of Abionyx Pharma SA logo

Abionyx Pharma SA

fr flag iconEuronext - Paris

Picture of Abivax SA logo

Abivax SA

fr flag iconEuronext - Paris

Picture of Acticor Biotech SA logo

Acticor Biotech SA

fr flag iconEuronext - Paris

Picture of Adocia SA logo

Adocia SA

fr flag iconEuronext - Paris

Picture of Biophytis SA logo

Biophytis SA

fr flag iconEuronext - Paris

FAQ